We selected serums from 51 fully characterized prostate cancer patients and 48 biopsy-proven BPH patients in order to test the ability of the ratio of the free/total PSA in distinguishing between CaP and BPH patients in the best case scenario. The 51 cancer patients had cancer volumes ranging from 2.0-17.8 mL and had a median % free PSA of 8.9%.
UVG4Q. nt2091hyz3.pages.dev/256nt2091hyz3.pages.dev/290nt2091hyz3.pages.dev/300nt2091hyz3.pages.dev/47nt2091hyz3.pages.dev/277nt2091hyz3.pages.dev/331nt2091hyz3.pages.dev/360nt2091hyz3.pages.dev/389nt2091hyz3.pages.dev/167
complexed psa vs free psa
